Table 1.
Sample characteristics.
| Sample type | Negative mNGS cases | Positive mNGS cases |
|---|---|---|
| Blood | 130 (42.2%) | 211 (29.6%) |
| Tissue | 63 (20.45%) | 136 (19.1%) |
| BALF | 33 (10.7%) | 125 (17.5%) |
| Sputum | 28 (9%) | 131 (18.4%) |
| Pleural fluid | 24 (7.79%) | 20 (2.8%) |
| CSF | 12 (3.9%) | 26 (3.6%) |
| Ascitic fluid | 6 (1.95%) | 8 (1.12%) |
| Pericardial fluid | 4 (1.3%) | 3 (0.42%) |
| Pus | 3 (1%) | 28 (3.92%) |
| Swab | 3 (1%) | 8 (1.12%) |
| Joint fluid | 1 (0.3%) | 0 (0.00%) |
| Drainage fluid | 1 (0.3%) | 3 (0.42%) |
| Bile | 0 (0.00%) | 5 (0.7%) |
| Stool | 0 (0.00%) | 1 (0.14%) |
| Urine | 0 (0.00%) | 8 (1.12%) |
| Total | 308 | 713 |
mNGS, metagenomics next-generation sequencing; BALF, bronchoalveolar lavage fluid; CSF, cerebrospinal fluid.